Published in
Public Library of Science, PLoS ONE, 8(11), p. e0159672, 2016
DOI: 10.1371/journal.pone.0159672
Links
- ORCID
- Public Library of Science
- ORCID
- [hdl.handle.net] | PDF
- [hdl.handle.net]
- [rabida.uhu.es] | PDF
- [repositorio.unican.es] | PDF
- [digibuo.uniovi.es] | PDF
- [repositori.upf.edu] | PDF
- [diposit.ub.edu] | PDF
- [europepmc.org] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study
Journal article published in 2016 by
Inés Gómez Acebo,
Trinidad Dierssen Sotos,
Camilo Palazuelos,
Beatriz Pérez Gómez,
Virginia Lope 
,
Ignasi Tusquets,
M. Henar Alonso,
M. Henar Alonso,
Victor Moreno,
Pilar Amiano,
Antonio José Molina de la Torre,
Aurelio Barricarte,
Adonina Tardón,
Antonio Camacho,
Rosana Peiro Pérez
and other authors.
,
Ignasi Tusquets,
M. Henar Alonso,
M. Henar Alonso,
Victor Moreno,
Pilar Amiano,
Antonio José Molina de la Torre,
Aurelio Barricarte,
Adonina Tardón,
Antonio Camacho,
Rosana Peiro Pérez
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
The evidence on the relationship between breast cancer and different types of antihypertensive drugs taken for at least 5 years is limited and inconsistent. Furthermore, the debate has recently been fueled again with new data reporting an increased risk of breast cancer among women with a long history of use of antihypertensive drugs compared with nonusers.